Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Survodutide

SYNCHRONIZE™-2

Boehringer Ingelheim · Phase 3 · Completed · Enrollment 755

NCT06066528

ArmPopulationDoseWeeksEstimandWeight change
Survodutide 3.6 mgObesity + T2D3.6 mgn/rn/rn/r
Survodutide 6.0 mgObesity + T2D6.0 mgn/rn/rn/r
PlaceboObesity + T2Dn/rn/rn/rn/r